Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences.

Cuesta AM, Sánchez-Martín D, Sanz L, Bonet J, Compte M, Kremer L, Blanco FJ, Oliva B, Alvarez-Vallina L.

PLoS One. 2009;4(4):e5381. doi: 10.1371/journal.pone.0005381. Epub 2009 Apr 29.

2.

L36-Cy5 anti-laminin trimerbody.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 Jun 11 [updated 2009 Aug 18].

3.

MFE23-Cy5 anti-carcinoembryonic antigen trimerbody.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 Jun 11 [updated 2009 Aug 18].

4.

Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.

Xu X, Clarke P, Szalai G, Shively JE, Williams LE, Shyr Y, Shi E, Primus FJ.

Cancer Res. 2000 Aug 15;60(16):4475-84.

5.

Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.

Wu AM, Chen W, Raubitschek A, Williams LE, Neumaier M, Fischer R, Hu SZ, Odom-Maryon T, Wong JY, Shively JE.

Immunotechnology. 1996 Feb;2(1):21-36.

PMID:
9373325
6.

Improved stability of multivalent antibodies containing the human collagen XV trimerization domain.

Cuesta AM, Sánchez-Martín D, Blanco-Toribio A, Villate M, Enciso-Álvarez K, Alvarez-Cienfuegos A, Sainz-Pastor N, Sanz L, Blanco FJ, Alvarez-Vallina L.

MAbs. 2012 Mar-Apr;4(2):226-32. doi: 10.4161/mabs.4.2.19140. Epub 2012 Mar 1.

7.
8.

Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.

Pavoni E, Flego M, Dupuis ML, Barca S, Petronzelli F, Anastasi AM, D'Alessio V, Pelliccia A, Vaccaro P, Monteriù G, Ascione A, De Santis R, Felici F, Cianfriglia M, Minenkova O.

BMC Cancer. 2006 Feb 24;6:41.

9.

Generation and characterization of monospecific and bispecific hexavalent trimerbodies.

Blanco-Toribio A, Sainz-Pastor N, Álvarez-Cienfuegos A, Merino N, Cuesta ÁM, Sánchez-Martín D, Bonet J, Santos-Valle P, Sanz L, Oliva B, Blanco FJ, Álvarez-Vallina L.

MAbs. 2013 Jan-Feb;5(1):70-9. doi: 10.4161/mabs.22698. Epub 2012 Dec 5.

10.

Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.

Asano R, Kudo T, Nishimura Y, Makabe K, Hayashi H, Suzuki M, Tsumoto K, Kumagai I.

J Biochem. 2002 Dec;132(6):903-9.

11.

Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting.

Olafsen T, Tan GJ, Cheung CW, Yazaki PJ, Park JM, Shively JE, Williams LE, Raubitschek AA, Press MF, Wu AM.

Protein Eng Des Sel. 2004 Apr;17(4):315-23. Epub 2004 Jun 8.

PMID:
15187222
12.

The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.

Wittel UA, Jain M, Goel A, Chauhan SC, Colcher D, Batra SK.

Nucl Med Biol. 2005 Feb;32(2):157-64.

PMID:
15721761
13.

Noninvasive localization of tumors by immunofluorescence imaging using a single chain Fv fragment of a human monoclonal antibody with broad cancer specificity.

Ramjiawan B, Maiti P, Aftanas A, Kaplan H, Fast D, Mantsch HH, Jackson M.

Cancer. 2000 Sep 1;89(5):1134-44.

PMID:
10964344
14.

Antigen specificity and tumour targeting efficiency of a human carcinoembryonic antigen-specific scFv and affinity-matured derivatives.

Jackson H, Bacon L, Pedley RB, Derbyshire E, Field A, Osbourn J, Allen D.

Br J Cancer. 1998 Jul;78(2):181-8.

15.

PEGylation and multimerization of the anti-p185HER-2 single chain Fv fragment 4D5: effects on tumor targeting.

Kubetzko S, Balic E, Waibel R, Zangemeister-Wittke U, Plückthun A.

J Biol Chem. 2006 Nov 17;281(46):35186-201. Epub 2006 Sep 8.

16.

Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging.

Venisnik KM, Olafsen T, Gambhir SS, Wu AM.

Mol Imaging Biol. 2007 Sep-Oct;9(5):267-77.

PMID:
17577599
17.
18.

Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.

Behar G, Chames P, Teulon I, Cornillon A, Alshoukr F, Roquet F, Pugnière M, Teillaud JL, Gruaz-Guyon A, Pèlegrin A, Baty D.

FEBS J. 2009 Jul;276(14):3881-93. doi: 10.1111/j.1742-4658.2009.07101.x. Epub 2009 Jun 15.

19.

Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library.

Begent RH, Verhaar MJ, Chester KA, Casey JL, Green AJ, Napier MP, Hope-Stone LD, Cushen N, Keep PA, Johnson CJ, Hawkins RE, Hilson AJ, Robson L.

Nat Med. 1996 Sep;2(9):979-84.

PMID:
8782454
20.

Bifunctional antibody-Renilla luciferase fusion protein for in vivo optical detection of tumors.

Venisnik KM, Olafsen T, Loening AM, Iyer M, Gambhir SS, Wu AM.

Protein Eng Des Sel. 2006 Oct;19(10):453-60. Epub 2006 Jul 31.

PMID:
16882674

Supplemental Content

Support Center